Correction to: short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study
Orphanet J Rare Dis. 2024 Aug 30;19(1):317.
doi: 10.1186/s13023-024-03305-8.
1 Glycogen Storage Disease Program, Connecticut Children's Medical Center, Hartford, USA. [email protected].
2 School of Medicine, Department of Pediatrics, University of Connecticut, Farmington, CT, USA. [email protected].
3 Liverpool Clinical Trials Centre, University of LiverpoolUK, Liverpool, UK.
4 Vitaflo International Ltd, 182 Sefton Street, Liverpool, UK.
5 Glycogen Storage Disease Program, Connecticut Children's Medical Center, Hartford, USA.
6 Metabolic Medicine, Great Ormond Street Hospital, London, UK.
7 Division of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands.
8 Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
9 Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK.
10 Evelina London Childrens Hospital, Westminster Bridge Road, London, UK.
11 Centre de Référence des Maladies héréditaires du Métabolisme Hépatique, APHP, Hôpitaux Universitaires Paris-Saclay, Hôpital Antoine Béclère, Paris-Saclay University, Clamart, Paris, France.
12 Medical Center, National Hospital of the Faroe Islands, Tórshavn, Faroe Islands.